U.S. opens tariff probe targeting Germany’s drug pricing policies

The U.S. has launched an investigation into Germany’s pharma policies over what it referred to as “persistent underpayment” for medicines as the European country looks to limit spiraling healthcare costs, including spending on drugs.  “President Trump has made clear that American patients should not be shouldering a disproportionate share of global pharmaceutical research and development,”…

Read More

Vance on the clock with Iran deal under fire 

In today’s issue: Vice President Vance is now officially set to negotiate a nuclear deal with Iran, as he faces political criticism from all sides for his leading role in an accord that failed to extract key concessions from Tehran. The Vice President’s role as the public face of Iran talks was further cemented yesterday…

Read More

Who are SpaceX’s billionaire shareholders?

SpaceX‘s record-breaking IPO boosted founder and CEO’s Elon Musk‘s personal stake in the company to more than $1 trillion. But he isn’t the only one seeing huge gains from SpaceX’s blockbuster listing. The IPO also minted thousands of new millionaires — and saw stakes of some shareholders surpass the billion-dollar mark. SpaceX’s debut week on…

Read More